Inspire Medical Systems, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4577301090
USD
68.05
8.8 (14.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Penumbra, Inc.
Inspire Medical Systems, Inc.
Insulet Corp.
Bruker Corp.
Shockwave Medical, Inc.
QIAGEN NV
Bio-Rad Laboratories, Inc.
EXACT Sciences Corp.
Bausch + Lomb Corp.
Teleflex, Inc.
Dentsply Sirona, Inc.

Why is Inspire Medical Systems, Inc. ?

1
Poor Management Efficiency with a low ROE of 2.09%
  • The company has been able to generate a Return on Equity (avg) of 2.09% signifying low profitability per unit of shareholders funds
2
With ROE of 10.46%, it has a attractive valuation with a 6.31 Price to Book Value
  • Over the past year, while the stock has generated a return of -28.74%, its profits have risen by 522.8% ; the PEG ratio of the company is 0.1
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -28.74% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Inspire Medical Systems, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Inspire Medical Systems, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Inspire Medical Systems, Inc.
-65.39%
-0.22
68.02%
S&P 500
12.95%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
51.21%
EBIT Growth (5y)
23.79%
EBIT to Interest (avg)
-15.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.58
Sales to Capital Employed (avg)
1.17
Tax Ratio
7.59%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.71%
ROE (avg)
2.09%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
42
Industry P/E
Price to Book Value
3.53
EV to EBIT
50.50
EV to EBITDA
40.06
EV to Capital Employed
5.52
EV to Sales
2.43
PEG Ratio
0.05
Dividend Yield
NA
ROCE (Latest)
10.92%
ROE (Latest)
8.43%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
ROCE(HY)

Highest at 19.77%

RAW MATERIAL COST(Y)

Fallen by -1.9% (YoY

NET SALES(Q)

Highest at USD 269.08 MM

OPERATING PROFIT(Q)

Highest at USD 49.93 MM

OPERATING PROFIT MARGIN(Q)

Highest at 18.56 %

PRE-TAX PROFIT(Q)

Highest at USD 50.32 MM

NET PROFIT(Q)

Highest at USD 136.09 MM

EPS(Q)

Highest at USD 4.65

-13What is not working for the Company
INTEREST(HY)

At USD 0.13 MM has Grown at 504.55%

DEBT-EQUITY RATIO (HY)

Highest at -35.35 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.18 times

Here's what is working for Inspire Medical Systems, Inc.

Net Profit
At USD 136.09 MM has Grown at 286.36%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
Highest at USD 269.08 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 49.93 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 18.56 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 50.32 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 136.09 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 4.65
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -1.9% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 3.82 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Inspire Medical Systems, Inc.

Interest
At USD 0.13 MM has Grown at 504.55%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio
Highest at -35.35 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 1.18 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio